XJPX9989
Market cap2.94bUSD
Dec 25, Last price
3,951.00JPY
1D
0.79%
1Q
-8.44%
Jan 2017
-2.32%
Name
Sundrug Co Ltd
Chart & Performance
Profile
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 751,777,000 8.88% | 690,462,000 6.43% | 648,734,000 2.27% | |||||||
Cost of revenue | 710,780,000 | 518,516,000 | 492,228,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 40,997,000 | 171,946,000 | 156,506,000 | |||||||
NOPBT Margin | 5.45% | 24.90% | 24.12% | |||||||
Operating Taxes | 12,134,000 | 12,007,000 | 10,821,000 | |||||||
Tax Rate | 29.60% | 6.98% | 6.91% | |||||||
NOPAT | 28,863,000 | 159,939,000 | 145,685,000 | |||||||
Net income | 29,126,000 13.32% | 25,703,000 7.76% | 23,853,000 -5.83% | |||||||
Dividends | (12,511,000) | (10,053,000) | (8,187,000) | |||||||
Dividend yield | 2.29% | 2.37% | 2.35% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 35,000,000 | 85,000 | 48,000 | |||||||
Long-term debt | 793,000 | 854,000 | 481,000 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 10,556,000 | 10,052,000 | 9,131,000 | |||||||
Net debt | (77,260,000) | (109,361,000) | (116,226,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 41,188,000 | 37,380,000 | 31,682,000 | |||||||
CAPEX | (36,426,000) | (26,113,000) | (19,789,000) | |||||||
Cash from investing activities | (74,850,000) | (28,512,000) | (20,659,000) | |||||||
Cash from financing activities | 22,487,000 | (17,326,000) | (8,187,000) | |||||||
FCF | 21,646,000 | 113,059,000 | 133,476,000 | |||||||
Balance | ||||||||||
Cash | 69,698,000 | 80,872,000 | 89,330,000 | |||||||
Long term investments | 43,355,000 | 29,428,000 | 27,425,000 | |||||||
Excess cash | 75,464,150 | 75,776,900 | 84,318,300 | |||||||
Stockholders' equity | 251,203,000 | 470,916,000 | 439,668,000 | |||||||
Invested Capital | 223,180,850 | 162,438,100 | 140,253,700 | |||||||
ROIC | 14.97% | 105.68% | 110.32% | |||||||
ROCE | 13.68% | 71.87% | 69.69% | |||||||
EV | ||||||||||
Common stock shares outstanding | 116,943 | 116,931 | 116,923 | |||||||
Price | 4,667.00 28.39% | 3,635.00 22.18% | 2,975.00 -26.54% | |||||||
Market cap | 545,771,572 28.40% | 425,044,585 22.19% | 347,847,317 -26.54% | |||||||
EV | 468,511,572 | 553,762,585 | 454,189,317 | |||||||
EBITDA | 56,239,000 | 184,014,000 | 166,715,000 | |||||||
EV/EBITDA | 8.33 | 3.01 | 2.72 | |||||||
Interest | 32,000 | 36,000 | 9,000 | |||||||
Interest/NOPBT | 0.08% | 0.02% | 0.01% |